CD8A and neoplasm: Whereas PBT treatment significantly reduced CT26.CL25 tumor growth in mice possessing a full complement of CD4+ and CD8+ T-cells (Figure 5A and 5B), PBT treatment had no significant inhibitory effects on tumor growth in mice that had received anti-CD4/CD8 antibodies (Figure 5A).